Mesoblast (MESO) Equity Ratio (2016 - 2024)
Historic Equity Ratio for Mesoblast (MESO) over the last 10 years, with Q4 2024 value amounting to 0.71.
- Mesoblast's Equity Ratio fell 697.61% to 0.71 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.71, marking a year-over-year decrease of 697.61%. This contributed to the annual value of 0.72 for FY2024, which is 424.34% down from last year.
- Mesoblast's Equity Ratio amounted to 0.71 in Q4 2024, which was down 697.61% from 0.72 recorded in Q2 2024.
- Over the past 5 years, Mesoblast's Equity Ratio peaked at 0.78 during Q1 2021, and registered a low of 0.71 during Q4 2024.
- Over the past 5 years, Mesoblast's median Equity Ratio value was 0.75 (recorded in 2020), while the average stood at 0.75.
- Its Equity Ratio has fluctuated over the past 5 years, first surged by 705.53% in 2021, then tumbled by 697.61% in 2024.
- Quarter analysis of 5 years shows Mesoblast's Equity Ratio stood at 0.75 in 2020, then rose by 0.72% to 0.76 in 2021, then decreased by 1.55% to 0.75 in 2022, then increased by 1.41% to 0.76 in 2023, then decreased by 6.98% to 0.71 in 2024.
- Its Equity Ratio stands at 0.71 for Q4 2024, versus 0.72 for Q2 2024 and 0.76 for Q4 2023.